SARS-CoV-2 Neutralization Test [ELISA: ACE2-RBD Neutralizing Antibodies]SARS-CoV-2 Neutralization Test [ELISA: ACE2-RBD Neutralizing Antibodies]

SARS-CoV-2 Neutralization Test [ELISA: ACE2-RBD Neutralizing Antibodies]

The test code ACE2-RBDNEUTR.CE is a CE-marked ELISA able to monitor the neutralizing activity of antibodies produced to SARS-CoV-2 Spike antigen by a natural infection or a specific vaccine.

The assay is intended for:


a)      Vaccination Follow Up: Determination of its actual effectiveness in providing protection to SARS-CoV-2.

b)     Follow Up of natural infection: Natural development of neutralizing antibodies and selection of pre-vaccination populations.

c)      Selection of hyperimmune plasmas with truly neutralizing antibodies for immunotherapy in COVID-19 patients

Order Information

Test Items

ACE2-RBDNEUTR.CE

Determination of   the neutralizing activity of anti-SARS-CoV-2 antibodies by ACE2-RBD binding   inhibition




SARS-CoV-2 Neutralization Test [ELISA: ACE2-RBD Neutralizing Antibodies]

√  User friendly ELISA standard format for any analytical laboratory

√  Fast in execution: results in less than 2 hours

√  Automation Friendly: Easily adaptable to any ELISA workstation

√  Provides 2 tests in one kit

√  Detection of antibodies that inhibit ACE2-RBD binding

√  Titration of neutralizing antibodies with Limit Dilutions

√  99% correlation with the "in vivo" Neutralization Test


SARS-CoV-2 Neutralization Test [ELISA: ACE2-RBD Neutralizing Antibodies]

√  Clinical laboratories

√  Independent laboratories


BUY